The treatments cost more and, at least in the case of prostate surgeries and hysterectomies, there's no evidence they do a better job, yet as National Public Radio put it, "it's hard to resist a robot." Especially for older men.
For men who undergo a biopsy for a prostate tumor, the big question has been whether to wait and see if the cancer grows slowly, or to treat it immediately with a regimen that could cause incontinence or impotence.
The following is a guest post by Jerry Bembry, journalism professor at Morgan State University.
For men in their 60s who are diagnosed with early-state prostate cancer, surgery doesn't help them live significantly longer than those who wait and monitor the slow-growing disease, a landmark new study finds.
For nearly two decades, middle-aged men have been told by their doctors to have a routine PSA test to screen for prostate cancer.
When 81-year-old billionaire investor Warren Buffett recently revealed he had been diagnosed with early-stage prostate cancer after a routine screening blood test, many health experts wondered why a man of his age was even being tested for prostate cancer.
Search AARP Blogs